Novo Nordisk is now worth more than Elon Musk’s electric vehicle giant Tesla, after shares of the Danish maker of Ozempic surged following the release of promising results for an oral weight loss treatment. But is it all good? Why are companies not talking about the side-effects or the harmful effects? Palki Sharma tells you.
